Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,119.93
(
0.79%
)
US TECH 100
26,137.40
(
1.41%
)
Dow Jones
49,361.10
(
-0.17%
)
Brent Oil
96.94
(
2.03%
)
Bitcoin
78,826.86
(
3.27%
)
News Focus
News Focus
Post# of 822425
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor082

Send PM Follow Ignore
Followers 4
Posts 5081
Boards Moderated 1
Alias Born 03/21/2024

Investor082

Re: dennisdave post# 791714

Wednesday, 10/08/2025 9:49:12 PM

Wednesday, October 08, 2025 9:49:12 PM

Post# of 822425
LOL, new excuses! From approval in March-April to now trying to convince yourself that delays are due to MHRA shaping new regulatory framework because of DCVAX-L.

If MHRA was that convinced, DCVAX-L would have been approved a while back. Besides, MHRA wouldn’t be holding up approval for a highly unmet disease until the official guidelines and frameworks catch up. MHRA already confirmed that this wasn’t necessary if the data was really convincing.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News